tiprankstipranks
Travere Therapeutics (TVTX)
NASDAQ:TVTX

Compare Travere Therapeutics (TVTX) vs. Competitors

596 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Travere Therapeutics
$28.96
$2.67B
-67.82
114.68%
12 Buy
2 Hold
0 Sell
Strong Buy
Galapagos
$28.40
$1.88B
5.74
19.43%
0 Buy
1 Hold
1 Sell
Moderate Sell
Arcutis Biotherapeutics
$24.21
$3.00B
-228.91
80.13%
8 Buy
1 Hold
0 Sell
Strong Buy
Disc Medicine
$66.32
$2.53B
-13.21
88.25%
11 Buy
0 Hold
0 Sell
Strong Buy
Tarsus Pharmaceuticals
$72.56
$3.09B
-51.51
64.46%
8 Buy
1 Hold
0 Sell
Strong Buy
Recursion Pharmaceuticals
$3.28
$1.73B
-2.84
-27.27%
1 Buy
2 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
TVTX
Travere Therapeutics
28.96
14.13
95.28%
GLPG
Galapagos
28.40
4.20
17.36%
ARQT
Arcutis Biotherapeutics
24.21
11.27
87.09%
IRON
Disc Medicine
66.32
26.05
64.69%
TARS
Tarsus Pharmaceuticals
72.56
23.84
48.93%
RXRX
Recursion Pharmaceuticals
3.28
-2.23
-40.47%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts